{"gene":"B3GNT8","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":2005,"finding":"B3GNT8 (beta3Gn-T8) transfers GlcNAc to the non-reducing terminus of Galbeta1-4GlcNAc of tetraantennary N-glycans in vitro, demonstrating beta1,3-N-acetylglucosaminyltransferase activity involved in poly-N-acetyllactosamine chain biosynthesis on beta1,6-branched N-glycans. HCT15 cells transfected with beta3Gn-T8 cDNA showed increased reactivity to LEA and PHA-L4 lectins.","method":"In vitro enzymatic assay; cDNA transfection in HCT15 cells with flow cytometric lectin binding analysis","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro enzymatic assay combined with cell-based functional validation; replicated in independent study (PMID:15917431)","pmids":["15620693"],"is_preprint":false},{"year":2005,"finding":"B3GNT8 preferentially recognizes tetraantennary N-glycans and 2,6-branched triantennary glycans over 2,4-branched triantennary glycans, biantennary glycans, and lacto-N-neotetraose, indicating specificity for 2,6-branched structures. Mixing recombinant beta3Gn-T2 and beta3Gn-T8 increased Vmax/Km 9.3-fold over beta3Gn-T2 alone and 160-fold over beta3Gn-T8 alone, and gel filtration showed they form a heterocomplex of ~110-210 kDa with enhanced enzymatic activity.","method":"Recombinant soluble enzyme expressed in Pichia pastoris; in vitro enzymatic assay with defined glycan substrates; Sephacryl S-300 gel filtration to assess complex formation","journal":"Glycobiology","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted in vitro with recombinant enzymes, substrate specificity profiling with multiple glycan substrates, and biochemical size-exclusion chromatography to demonstrate complex formation; followed up by independent replication (PMID:18826941)","pmids":["15917431"],"is_preprint":false},{"year":2008,"finding":"B3GNT8 and beta3Gn-T2 co-immunoprecipitate from lysates of co-transfected COS-7 cells, confirming in vivo association. Inactive DXD-motif mutant of beta3Gn-T8 mixed with intact beta3Gn-T2 showed increased activity (beta3Gn-T2 is activated), while mutant beta3Gn-T2 mixed with intact beta3Gn-T8 showed no activation, demonstrating that B3GNT8 activates beta3Gn-T2 through complex formation rather than contributing its own catalytic activity. Overexpression of B3GNT8 (but not beta3Gn-T2) in HL-60 cells increased poly-N-acetyllactosamine chains, suggesting B3GNT8 upregulation drives poly-LacNAc biosynthesis by activating intrinsic beta3Gn-T2.","method":"Co-immunoprecipitation from co-transfected COS-7 cells; DXD active-site mutagenesis with in vitro enzymatic activity measurement; overexpression in HL-60 cells with lectin-based glycan detection","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — reciprocal epistasis via catalytic-dead mutants establishes mechanism of activation; co-IP confirms in vivo interaction; functional overexpression validates cellular consequence; multiple orthogonal methods in one study","pmids":["18826941"],"is_preprint":false},{"year":2010,"finding":"siRNA-mediated knockdown of B3GNT8 in AGS gastric cancer cells reduced MMP-2 expression and activity (assessed by RT-PCR, western blot, and gelatin zymography) while increasing TIMP-2 expression, and decreased cell invasion through Matrigel. Conversely, overexpression of B3GNT8 increased MMP-2 expression, inhibited TIMP-2, and enhanced invasion, indicating B3GNT8 regulates MMP-2/TIMP-2 balance and invasive behavior.","method":"siRNA knockdown and plasmid overexpression in AGS cells; RT-PCR, western blot, gelatin zymography for MMP-2/TIMP-2; Matrigel invasion assay","journal":"Molecular biology reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function and gain-of-function with multiple readouts (mRNA, protein, activity, invasion), single lab; no direct mechanistic link between glycosyltransferase activity and MMP-2 regulation established","pmids":["20963502"],"is_preprint":false},{"year":2016,"finding":"Transcription factor c-jun binds to and activates the B3GNT8 promoter in SGC-7901 gastric cancer cells, as demonstrated by luciferase reporter assay and chromatin immunoprecipitation (ChIP). c-jun upregulation increases B3GNT8 expression and poly-LacNAc glycosylation activity, and also regulates levels of the glycoprotein substrate CD147 (HG-CD147).","method":"Luciferase reporter assay; chromatin immunoprecipitation (ChIP); RT-PCR and western blot; flow cytometry and immunofluorescence with LEA lectin; lectin blot","journal":"Oncology reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP confirms direct promoter binding, reporter assay confirms transcriptional activation, multiple orthogonal methods in single lab","pmids":["27459970"],"is_preprint":false},{"year":2025,"finding":"B3gnt8 knockout mice show heightened susceptibility to DSS-induced colitis with compromised tight junction integrity, impaired goblet cell mucin secretion, reduced Paneth cell populations and lysozyme content, altered intestinal microbiota composition, and impaired lysosomal stability potentially via reduced glycosylation of LAMP1/2. Mechanistically, B3gnt8 deficiency disrupted autophagy-lysosomal processes in Paneth cells via the ATG16L1-ATG12-ATG5 pathway.","method":"B3gnt8 knockout mouse model; DSS-induced colitis; histology, western blot, immunofluorescence for tight junction proteins, mucin, LAMP1/2; Paneth cell and lysozyme analyses; microbiota profiling","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockout with defined phenotypic readouts and mechanistic pathway (ATG16L1-ATG12-ATG5) proposed; single lab, single study; mechanistic link between glycosylation and autophagy pathway is partially inferred","pmids":["41380967"],"is_preprint":false},{"year":2017,"finding":"Functional analysis of B3gnt8 on recombinant Cav3.2 T-type calcium channels showed an unexpected loss-of-function of the channel, suggesting that B3GNT8-mediated glycosylation has a negative regulatory effect on Cav3.2 channel activity.","method":"Recombinant Cav3.2 expression with co-expressed glycan-processing enzymes including B3gnt8; electrophysiological functional characterization","journal":"Channels (Austin, Tex.)","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single functional readout on recombinant channel; negative/unexpected result noted in abstract without detailed mechanistic follow-up for B3GNT8 specifically; no mutagenesis or direct glycosylation site identification","pmids":["32233724"],"is_preprint":false}],"current_model":"B3GNT8 is a Golgi-localized beta-1,3-N-acetylglucosaminyltransferase that synthesizes poly-N-acetyllactosamine chains preferentially on tetraantennary and 2,6-branched N-glycans; its principal mechanism of action involves forming a heterocomplex with beta3Gn-T2 that dramatically enhances beta3Gn-T2 catalytic activity (via a non-catalytic scaffolding role of B3GNT8), and its expression is transcriptionally activated by c-jun; in vivo, B3GNT8-mediated glycosylation maintains intestinal epithelial homeostasis through glycosylation of lysosomal membrane proteins (LAMP1/2) and support of Paneth cell autophagy-lysosomal function via the ATG16L1-ATG12-ATG5 pathway."},"narrative":{"mechanistic_narrative":"B3GNT8 is a Golgi-type beta-1,3-N-acetylglucosaminyltransferase that builds poly-N-acetyllactosamine chains on complex N-glycans, acting preferentially on tetraantennary and 2,6-branched structures [PMID:15620693, PMID:15917431]. Its defining mechanistic feature is non-canonical: rather than functioning chiefly as a stand-alone catalyst, B3GNT8 forms a heterocomplex with beta3Gn-T2 and dramatically enhances beta3Gn-T2 activity, raising Vmax/Km roughly 9-fold over beta3Gn-T2 alone [PMID:15917431]. Reciprocal catalytic-dead mutagenesis established that a DXD-inactive B3GNT8 still activates intact beta3Gn-T2, whereas inactive beta3Gn-T2 is not activated, demonstrating that B3GNT8 drives poly-LacNAc biosynthesis primarily through a scaffolding/activating role on its partner enzyme [PMID:18826941]. B3GNT8 transcription is directly activated by c-jun, which binds the B3GNT8 promoter and increases poly-LacNAc glycosylation in gastric cancer cells [PMID:27459970], and B3GNT8 expression modulates the MMP-2/TIMP-2 balance and Matrigel invasion in these cells [PMID:20963502]. In vivo, B3gnt8 knockout mice are hypersusceptible to DSS-induced colitis with impaired tight-junction integrity, reduced Paneth cells and lysozyme, and disrupted autophagy-lysosomal function linked to reduced LAMP1/2 glycosylation and the ATG16L1-ATG12-ATG5 pathway, indicating a role in intestinal epithelial homeostasis [PMID:41380967].","teleology":[{"year":2005,"claim":"Establishing that B3GNT8 is a glycosyltransferase answered whether it could extend N-glycans, defining it as a beta-1,3-GlcNAc transferase that initiates poly-N-acetyllactosamine synthesis on branched N-glycans.","evidence":"In vitro enzymatic assay plus cDNA transfection in HCT15 cells with lectin (LEA, PHA-L4) flow cytometry","pmids":["15620693"],"confidence":"High","gaps":["Glycan branch preference not yet resolved","Endogenous physiological substrates not identified","No in vivo context"]},{"year":2005,"claim":"Substrate profiling and gel filtration answered how B3GNT8 contributes to poly-LacNAc synthesis, revealing both 2,6-branch specificity and the surprising formation of an activating heterocomplex with beta3Gn-T2.","evidence":"Recombinant soluble enzymes from Pichia pastoris, defined-substrate kinetics, and Sephacryl S-300 gel filtration","pmids":["15917431"],"confidence":"High","gaps":["Structural basis of the heterocomplex unknown","Stoichiometry of the ~110-210 kDa complex not defined","Mechanism of catalytic enhancement not established"]},{"year":2008,"claim":"Catalytic-dead epistasis answered whether B3GNT8's effect is enzymatic or scaffolding, showing it activates beta3Gn-T2 through complex formation rather than its own catalysis.","evidence":"Co-IP from co-transfected COS-7 cells, DXD active-site mutagenesis with activity measurement, and overexpression in HL-60 cells with lectin detection","pmids":["18826941"],"confidence":"High","gaps":["Interaction interface and structural mechanism unresolved","Whether B3GNT8 retains any independent catalytic role in vivo unclear","Regulation of complex assembly unknown"]},{"year":2010,"claim":"Loss- and gain-of-function in gastric cancer cells addressed a cellular consequence of B3GNT8, linking it to MMP-2/TIMP-2 balance and invasive behavior.","evidence":"siRNA knockdown and overexpression in AGS cells with RT-PCR, western blot, gelatin zymography, and Matrigel invasion assay","pmids":["20963502"],"confidence":"Medium","gaps":["No direct mechanistic link between glycosyltransferase activity and MMP-2 regulation established","Single lab, single cell line","Glycoprotein substrates mediating the effect not identified"]},{"year":2016,"claim":"Promoter analysis answered how B3GNT8 expression is controlled in cancer cells, identifying c-jun as a direct transcriptional activator that drives poly-LacNAc glycosylation.","evidence":"Luciferase reporter assay, ChIP, RT-PCR/western blot, and LEA lectin detection in SGC-7901 cells","pmids":["27459970"],"confidence":"Medium","gaps":["Upstream signals controlling c-jun in this context not defined","Direct link from CD147 glycosylation to phenotype not fully established","Single-lab evidence"]},{"year":2017,"claim":"A recombinant channel assay tested whether B3GNT8 glycosylation affects ion channel function, indicating a negative regulatory effect on Cav3.2 T-type calcium channels.","evidence":"Recombinant Cav3.2 co-expressed with glycan-processing enzymes and electrophysiological characterization","pmids":["32233724"],"confidence":"Low","gaps":["Single functional readout without mutagenesis or glycosylation-site mapping","B3GNT8-specific mechanism not isolated","No physiological validation"]},{"year":2025,"claim":"A knockout mouse addressed the in vivo physiological role of B3GNT8, demonstrating its requirement for intestinal epithelial homeostasis and Paneth cell autophagy-lysosomal function.","evidence":"B3gnt8 knockout mice with DSS-induced colitis; histology, western blot, immunofluorescence for tight junctions, mucin, LAMP1/2; Paneth cell and microbiota profiling","pmids":["41380967"],"confidence":"Medium","gaps":["Link between glycosylation and the ATG16L1-ATG12-ATG5 pathway is partially inferred","Direct demonstration that LAMP1/2 glycosylation drives lysosomal stability not shown","Single lab, single study"]},{"year":null,"claim":"How B3GNT8-dependent poly-LacNAc synthesis on specific glycoproteins mechanistically couples to downstream phenotypes (invasion, channel regulation, autophagy) remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of the B3GNT8-beta3Gn-T2 complex","Direct causal chain from glycan modification to cellular phenotype not established for any system","Physiological substrate repertoire incompletely defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,1,2]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[2]}],"localization":[],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,1,2]}],"complexes":["B3GNT8-beta3Gn-T2 (B3GNT2) heterocomplex"],"partners":["B3GNT2","JUN","CD147"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q7Z7M8","full_name":"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 8","aliases":["UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8","BGnT-8","Beta-1,3-Gn-T8","Beta-1,3-N-acetylglucosaminyltransferase 8","Beta3Gn-T8"],"length_aa":397,"mass_kda":43.4,"function":"Beta-1,3-N-acetylglucosaminyltransferase that functions in the elongation of specific branch structures of multiantennary N-glycans. Has strong activity towards tetraantennary N-glycans and 2,6 triantennary glycans","subcellular_location":"Golgi apparatus membrane","url":"https://www.uniprot.org/uniprotkb/Q7Z7M8/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/B3GNT8","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/B3GNT8","total_profiled":1310},"omim":[{"mim_id":"615357","title":"BETA-1,3-GALACTOSYLTRANSFERASE 8; B3GNT8","url":"https://www.omim.org/entry/615357"},{"mim_id":"605581","title":"BETA-1,3-N-ACETYLGLUCOSYAMINYLTRANSFERASE 2; B3GNT2","url":"https://www.omim.org/entry/605581"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"esophagus","ntpm":11.8},{"tissue":"intestine","ntpm":18.6}],"url":"https://www.proteinatlas.org/search/B3GNT8"},"hgnc":{"alias_symbol":["BGALT15","beta3Gn-T8"],"prev_symbol":["B3GALT7"]},"alphafold":{"accession":"Q7Z7M8","domains":[{"cath_id":"3.90.550.50","chopping":"133-392","consensus_level":"high","plddt":92.7083,"start":133,"end":392}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q7Z7M8","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q7Z7M8-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q7Z7M8-F1-predicted_aligned_error_v6.png","plddt_mean":87.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=B3GNT8","jax_strain_url":"https://www.jax.org/strain/search?query=B3GNT8"},"sequence":{"accession":"Q7Z7M8","fasta_url":"https://rest.uniprot.org/uniprotkb/Q7Z7M8.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q7Z7M8/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q7Z7M8"}},"corpus_meta":[{"pmid":"15620693","id":"PMC_15620693","title":"A novel beta1,3-N-acetylglucosaminyltransferase (beta3Gn-T8), which synthesizes poly-N-acetyllactosamine, is dramatically upregulated in colon cancer.","date":"2005","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/15620693","citation_count":76,"is_preprint":false},{"pmid":"15917431","id":"PMC_15917431","title":"Characterization of a novel galactose beta1,3-N-acetylglucosaminyltransferase (beta3Gn-T8): the complex formation of beta3Gn-T2 and beta3Gn-T8 enhances enzymatic activity.","date":"2005","source":"Glycobiology","url":"https://pubmed.ncbi.nlm.nih.gov/15917431","citation_count":44,"is_preprint":false},{"pmid":"18826941","id":"PMC_18826941","title":"Activation of beta1,3-N-acetylglucosaminyltransferase-2 (beta3Gn-T2) by beta3Gn-T8. Possible involvement of beta3Gn-T8 in increasing poly-N-acetyllactosamine chains in differentiated HL-60 cells.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18826941","citation_count":38,"is_preprint":false},{"pmid":"22579717","id":"PMC_22579717","title":"Glycomic alterations are associated with multidrug resistance in human leukemia.","date":"2012","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/22579717","citation_count":38,"is_preprint":false},{"pmid":"26104473","id":"PMC_26104473","title":"Abnormal N-acetylglucosaminyltransferase expression in prefrontal cortex in schizophrenia.","date":"2015","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/26104473","citation_count":34,"is_preprint":false},{"pmid":"37592229","id":"PMC_37592229","title":"Identifying causal genes for migraine by integrating the proteome and transcriptome.","date":"2023","source":"The journal of headache and pain","url":"https://pubmed.ncbi.nlm.nih.gov/37592229","citation_count":30,"is_preprint":false},{"pmid":"37212950","id":"PMC_37212950","title":"Novel Drug Targets for Atrial Fibrillation Identified Through Mendelian Randomization Analysis of the Blood Proteome.","date":"2023","source":"Cardiovascular drugs and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/37212950","citation_count":25,"is_preprint":false},{"pmid":"24604396","id":"PMC_24604396","title":"Colon cancer cells treated with 5‑fluorouracil exhibit changes in polylactosamine‑type N‑glycans.","date":"2014","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/24604396","citation_count":22,"is_preprint":false},{"pmid":"38572516","id":"PMC_38572516","title":"Identification of prospective aging drug targets via Mendelian randomization analysis.","date":"2024","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/38572516","citation_count":20,"is_preprint":false},{"pmid":"32945502","id":"PMC_32945502","title":"N‑glycosylation and receptor tyrosine kinase signaling affect claudin‑3 levels in colorectal cancer cells.","date":"2020","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/32945502","citation_count":20,"is_preprint":false},{"pmid":"15486459","id":"PMC_15486459","title":"Cloning and tissue distribution of the human B3GALT7 gene, a member of the beta1,3-Glycosyltransferase family.","date":"2004","source":"Glycoconjugate journal","url":"https://pubmed.ncbi.nlm.nih.gov/15486459","citation_count":19,"is_preprint":false},{"pmid":"21468598","id":"PMC_21468598","title":"Down-regulation of β-1,3-N-acetylglucosaminyltransferase-8 by siRNA inhibits the growth of human gastric cancer.","date":"2011","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/21468598","citation_count":14,"is_preprint":false},{"pmid":"20963502","id":"PMC_20963502","title":"Regulation of MMP-2 expression and activity by β-1,3-N-acetylglucosaminyltransferase-8 in AGS gastric cancer cells.","date":"2010","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/20963502","citation_count":13,"is_preprint":false},{"pmid":"40264196","id":"PMC_40264196","title":"Integrating multi-cohort machine learning and clinical sample validation to explore peripheral blood mRNA diagnostic biomarkers for prostate cancer.","date":"2025","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/40264196","citation_count":9,"is_preprint":false},{"pmid":"27459970","id":"PMC_27459970","title":"Transcription factor c-jun regulates β3Gn-T8 expression in gastric cancer cell line SGC-7901.","date":"2016","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/27459970","citation_count":4,"is_preprint":false},{"pmid":"33517290","id":"PMC_33517290","title":"Biological and Clinicopathological Implications of Beta-3-N-acetylglucosaminyltransferase 8 in Triple-negative Breast Cancer.","date":"2021","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/33517290","citation_count":4,"is_preprint":false},{"pmid":"32233724","id":"PMC_32233724","title":"Transcriptomic analysis of glycan-processing genes in the dorsal root ganglia of diabetic mice and functional characterization on Cav3.2 channels.","date":"2020","source":"Channels (Austin, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/32233724","citation_count":4,"is_preprint":false},{"pmid":"38778174","id":"PMC_38778174","title":"Exploration of potential novel drug targets for diabetic retinopathy by plasma proteome screening.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/38778174","citation_count":3,"is_preprint":false},{"pmid":"41380967","id":"PMC_41380967","title":"B3GNT8-mediated glycosylation maintains intestinal homeostasis and protects against colitis.","date":"2025","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/41380967","citation_count":0,"is_preprint":false},{"pmid":"39843866","id":"PMC_39843866","title":"Genetic insights into CRP levels in Indian adolescents: confirming adult genetic associations.","date":"2025","source":"Molecular genetics and genomics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/39843866","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":13057,"output_tokens":2468,"usd":0.038095,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9501,"output_tokens":2924,"usd":0.060303,"stage2_stop_reason":"end_turn"},"total_usd":0.098398,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"B3GNT8 (beta3Gn-T8) transfers GlcNAc to the non-reducing terminus of Galbeta1-4GlcNAc of tetraantennary N-glycans in vitro, demonstrating beta1,3-N-acetylglucosaminyltransferase activity involved in poly-N-acetyllactosamine chain biosynthesis on beta1,6-branched N-glycans. HCT15 cells transfected with beta3Gn-T8 cDNA showed increased reactivity to LEA and PHA-L4 lectins.\",\n      \"method\": \"In vitro enzymatic assay; cDNA transfection in HCT15 cells with flow cytometric lectin binding analysis\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro enzymatic assay combined with cell-based functional validation; replicated in independent study (PMID:15917431)\",\n      \"pmids\": [\"15620693\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"B3GNT8 preferentially recognizes tetraantennary N-glycans and 2,6-branched triantennary glycans over 2,4-branched triantennary glycans, biantennary glycans, and lacto-N-neotetraose, indicating specificity for 2,6-branched structures. Mixing recombinant beta3Gn-T2 and beta3Gn-T8 increased Vmax/Km 9.3-fold over beta3Gn-T2 alone and 160-fold over beta3Gn-T8 alone, and gel filtration showed they form a heterocomplex of ~110-210 kDa with enhanced enzymatic activity.\",\n      \"method\": \"Recombinant soluble enzyme expressed in Pichia pastoris; in vitro enzymatic assay with defined glycan substrates; Sephacryl S-300 gel filtration to assess complex formation\",\n      \"journal\": \"Glycobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted in vitro with recombinant enzymes, substrate specificity profiling with multiple glycan substrates, and biochemical size-exclusion chromatography to demonstrate complex formation; followed up by independent replication (PMID:18826941)\",\n      \"pmids\": [\"15917431\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"B3GNT8 and beta3Gn-T2 co-immunoprecipitate from lysates of co-transfected COS-7 cells, confirming in vivo association. Inactive DXD-motif mutant of beta3Gn-T8 mixed with intact beta3Gn-T2 showed increased activity (beta3Gn-T2 is activated), while mutant beta3Gn-T2 mixed with intact beta3Gn-T8 showed no activation, demonstrating that B3GNT8 activates beta3Gn-T2 through complex formation rather than contributing its own catalytic activity. Overexpression of B3GNT8 (but not beta3Gn-T2) in HL-60 cells increased poly-N-acetyllactosamine chains, suggesting B3GNT8 upregulation drives poly-LacNAc biosynthesis by activating intrinsic beta3Gn-T2.\",\n      \"method\": \"Co-immunoprecipitation from co-transfected COS-7 cells; DXD active-site mutagenesis with in vitro enzymatic activity measurement; overexpression in HL-60 cells with lectin-based glycan detection\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — reciprocal epistasis via catalytic-dead mutants establishes mechanism of activation; co-IP confirms in vivo interaction; functional overexpression validates cellular consequence; multiple orthogonal methods in one study\",\n      \"pmids\": [\"18826941\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"siRNA-mediated knockdown of B3GNT8 in AGS gastric cancer cells reduced MMP-2 expression and activity (assessed by RT-PCR, western blot, and gelatin zymography) while increasing TIMP-2 expression, and decreased cell invasion through Matrigel. Conversely, overexpression of B3GNT8 increased MMP-2 expression, inhibited TIMP-2, and enhanced invasion, indicating B3GNT8 regulates MMP-2/TIMP-2 balance and invasive behavior.\",\n      \"method\": \"siRNA knockdown and plasmid overexpression in AGS cells; RT-PCR, western blot, gelatin zymography for MMP-2/TIMP-2; Matrigel invasion assay\",\n      \"journal\": \"Molecular biology reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function and gain-of-function with multiple readouts (mRNA, protein, activity, invasion), single lab; no direct mechanistic link between glycosyltransferase activity and MMP-2 regulation established\",\n      \"pmids\": [\"20963502\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Transcription factor c-jun binds to and activates the B3GNT8 promoter in SGC-7901 gastric cancer cells, as demonstrated by luciferase reporter assay and chromatin immunoprecipitation (ChIP). c-jun upregulation increases B3GNT8 expression and poly-LacNAc glycosylation activity, and also regulates levels of the glycoprotein substrate CD147 (HG-CD147).\",\n      \"method\": \"Luciferase reporter assay; chromatin immunoprecipitation (ChIP); RT-PCR and western blot; flow cytometry and immunofluorescence with LEA lectin; lectin blot\",\n      \"journal\": \"Oncology reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP confirms direct promoter binding, reporter assay confirms transcriptional activation, multiple orthogonal methods in single lab\",\n      \"pmids\": [\"27459970\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"B3gnt8 knockout mice show heightened susceptibility to DSS-induced colitis with compromised tight junction integrity, impaired goblet cell mucin secretion, reduced Paneth cell populations and lysozyme content, altered intestinal microbiota composition, and impaired lysosomal stability potentially via reduced glycosylation of LAMP1/2. Mechanistically, B3gnt8 deficiency disrupted autophagy-lysosomal processes in Paneth cells via the ATG16L1-ATG12-ATG5 pathway.\",\n      \"method\": \"B3gnt8 knockout mouse model; DSS-induced colitis; histology, western blot, immunofluorescence for tight junction proteins, mucin, LAMP1/2; Paneth cell and lysozyme analyses; microbiota profiling\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout with defined phenotypic readouts and mechanistic pathway (ATG16L1-ATG12-ATG5) proposed; single lab, single study; mechanistic link between glycosylation and autophagy pathway is partially inferred\",\n      \"pmids\": [\"41380967\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Functional analysis of B3gnt8 on recombinant Cav3.2 T-type calcium channels showed an unexpected loss-of-function of the channel, suggesting that B3GNT8-mediated glycosylation has a negative regulatory effect on Cav3.2 channel activity.\",\n      \"method\": \"Recombinant Cav3.2 expression with co-expressed glycan-processing enzymes including B3gnt8; electrophysiological functional characterization\",\n      \"journal\": \"Channels (Austin, Tex.)\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single functional readout on recombinant channel; negative/unexpected result noted in abstract without detailed mechanistic follow-up for B3GNT8 specifically; no mutagenesis or direct glycosylation site identification\",\n      \"pmids\": [\"32233724\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"B3GNT8 is a Golgi-localized beta-1,3-N-acetylglucosaminyltransferase that synthesizes poly-N-acetyllactosamine chains preferentially on tetraantennary and 2,6-branched N-glycans; its principal mechanism of action involves forming a heterocomplex with beta3Gn-T2 that dramatically enhances beta3Gn-T2 catalytic activity (via a non-catalytic scaffolding role of B3GNT8), and its expression is transcriptionally activated by c-jun; in vivo, B3GNT8-mediated glycosylation maintains intestinal epithelial homeostasis through glycosylation of lysosomal membrane proteins (LAMP1/2) and support of Paneth cell autophagy-lysosomal function via the ATG16L1-ATG12-ATG5 pathway.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"B3GNT8 is a Golgi-type beta-1,3-N-acetylglucosaminyltransferase that builds poly-N-acetyllactosamine chains on complex N-glycans, acting preferentially on tetraantennary and 2,6-branched structures [#0, #1]. Its defining mechanistic feature is non-canonical: rather than functioning chiefly as a stand-alone catalyst, B3GNT8 forms a heterocomplex with beta3Gn-T2 and dramatically enhances beta3Gn-T2 activity, raising Vmax/Km roughly 9-fold over beta3Gn-T2 alone [#1]. Reciprocal catalytic-dead mutagenesis established that a DXD-inactive B3GNT8 still activates intact beta3Gn-T2, whereas inactive beta3Gn-T2 is not activated, demonstrating that B3GNT8 drives poly-LacNAc biosynthesis primarily through a scaffolding/activating role on its partner enzyme [#2]. B3GNT8 transcription is directly activated by c-jun, which binds the B3GNT8 promoter and increases poly-LacNAc glycosylation in gastric cancer cells [#4], and B3GNT8 expression modulates the MMP-2/TIMP-2 balance and Matrigel invasion in these cells [#3]. In vivo, B3gnt8 knockout mice are hypersusceptible to DSS-induced colitis with impaired tight-junction integrity, reduced Paneth cells and lysozyme, and disrupted autophagy-lysosomal function linked to reduced LAMP1/2 glycosylation and the ATG16L1-ATG12-ATG5 pathway, indicating a role in intestinal epithelial homeostasis [#5].\",\n  \"teleology\": [\n    {\n      \"year\": 2005,\n      \"claim\": \"Establishing that B3GNT8 is a glycosyltransferase answered whether it could extend N-glycans, defining it as a beta-1,3-GlcNAc transferase that initiates poly-N-acetyllactosamine synthesis on branched N-glycans.\",\n      \"evidence\": \"In vitro enzymatic assay plus cDNA transfection in HCT15 cells with lectin (LEA, PHA-L4) flow cytometry\",\n      \"pmids\": [\"15620693\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Glycan branch preference not yet resolved\",\n        \"Endogenous physiological substrates not identified\",\n        \"No in vivo context\"\n      ]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Substrate profiling and gel filtration answered how B3GNT8 contributes to poly-LacNAc synthesis, revealing both 2,6-branch specificity and the surprising formation of an activating heterocomplex with beta3Gn-T2.\",\n      \"evidence\": \"Recombinant soluble enzymes from Pichia pastoris, defined-substrate kinetics, and Sephacryl S-300 gel filtration\",\n      \"pmids\": [\"15917431\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of the heterocomplex unknown\",\n        \"Stoichiometry of the ~110-210 kDa complex not defined\",\n        \"Mechanism of catalytic enhancement not established\"\n      ]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Catalytic-dead epistasis answered whether B3GNT8's effect is enzymatic or scaffolding, showing it activates beta3Gn-T2 through complex formation rather than its own catalysis.\",\n      \"evidence\": \"Co-IP from co-transfected COS-7 cells, DXD active-site mutagenesis with activity measurement, and overexpression in HL-60 cells with lectin detection\",\n      \"pmids\": [\"18826941\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Interaction interface and structural mechanism unresolved\",\n        \"Whether B3GNT8 retains any independent catalytic role in vivo unclear\",\n        \"Regulation of complex assembly unknown\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Loss- and gain-of-function in gastric cancer cells addressed a cellular consequence of B3GNT8, linking it to MMP-2/TIMP-2 balance and invasive behavior.\",\n      \"evidence\": \"siRNA knockdown and overexpression in AGS cells with RT-PCR, western blot, gelatin zymography, and Matrigel invasion assay\",\n      \"pmids\": [\"20963502\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No direct mechanistic link between glycosyltransferase activity and MMP-2 regulation established\",\n        \"Single lab, single cell line\",\n        \"Glycoprotein substrates mediating the effect not identified\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Promoter analysis answered how B3GNT8 expression is controlled in cancer cells, identifying c-jun as a direct transcriptional activator that drives poly-LacNAc glycosylation.\",\n      \"evidence\": \"Luciferase reporter assay, ChIP, RT-PCR/western blot, and LEA lectin detection in SGC-7901 cells\",\n      \"pmids\": [\"27459970\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Upstream signals controlling c-jun in this context not defined\",\n        \"Direct link from CD147 glycosylation to phenotype not fully established\",\n        \"Single-lab evidence\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"A recombinant channel assay tested whether B3GNT8 glycosylation affects ion channel function, indicating a negative regulatory effect on Cav3.2 T-type calcium channels.\",\n      \"evidence\": \"Recombinant Cav3.2 co-expressed with glycan-processing enzymes and electrophysiological characterization\",\n      \"pmids\": [\"32233724\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"Single functional readout without mutagenesis or glycosylation-site mapping\",\n        \"B3GNT8-specific mechanism not isolated\",\n        \"No physiological validation\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"A knockout mouse addressed the in vivo physiological role of B3GNT8, demonstrating its requirement for intestinal epithelial homeostasis and Paneth cell autophagy-lysosomal function.\",\n      \"evidence\": \"B3gnt8 knockout mice with DSS-induced colitis; histology, western blot, immunofluorescence for tight junctions, mucin, LAMP1/2; Paneth cell and microbiota profiling\",\n      \"pmids\": [\"41380967\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Link between glycosylation and the ATG16L1-ATG12-ATG5 pathway is partially inferred\",\n        \"Direct demonstration that LAMP1/2 glycosylation drives lysosomal stability not shown\",\n        \"Single lab, single study\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How B3GNT8-dependent poly-LacNAc synthesis on specific glycoproteins mechanistically couples to downstream phenotypes (invasion, channel regulation, autophagy) remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No structural model of the B3GNT8-beta3Gn-T2 complex\",\n        \"Direct causal chain from glycan modification to cellular phenotype not established for any system\",\n        \"Physiological substrate repertoire incompletely defined\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 1, 2]}\n    ],\n    \"complexes\": [\"B3GNT8-beta3Gn-T2 (B3GNT2) heterocomplex\"],\n    \"partners\": [\"B3GNT2\", \"JUN\", \"CD147\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":4,"faith_total":5,"faith_pct":80.0}}